Vikas EcoTech Q3 FY26: standalone loss widens to Rs 124 lakh, revenue down 18% YoY

Revenue DeclinePat NegativeExceptional ItemResults RestatedResults View source PDF Explain this filing

VIKASECO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.2%Reaction day

₹1.61

prior close

₹1.57

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.8%-5.4% vs market

Specialty Chemicals peers, median of 88sector-0.3%-5.9% vs sector

On the reaction day the stock moved 5.4 pts less than Nifty Microcap 250 and 5.9 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.5

10m

-3.8

15m

-3.8

30m

-4.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.2-0.8-5.4-0.3-5.9

Next day

-3.7+1.8-5.5+1.8-5.6

-3.1+2.8-5.9+2.0-5.1

-4.3+2.3-6.6+2.3-6.7

-6.2+1.8-8.0+1.4-7.6

-6.2+0.3-6.5-0.0-6.2

-5.6+0.5-6.1-1.2-4.4

15d

-13.0-2.5-10.5-3.8-9.2

-16.8-6.3-10.4-7.4-9.4

-23.0-8.0-15.0-8.4-14.6

-13.7+8.3-21.9+5.6-19.3

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 88Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Standalone Q3 FY26 revenue fell to Rs 5,006 lakhs from Rs 6,097 lakhs YoY, about an 18% decline. Nine month revenue dropped to Rs 17,959 lakhs from Rs 20,828 lakhs. Standalone Q3 PAT swung to a loss of Rs 124 lakhs versus a Rs 19 lakh loss YoY. Nine month standalone PAT was Rs 122 lakhs versus Rs 1,231 lakhs, the prior year boosted by a Rs 1,287 lakh exceptional gain. Consolidated Q3 revenue was Rs 6,872 lakhs and PAT was a loss of Rs 54 lakhs. EPS stood at minus Rs 0.01. Previous period figures were restated.

Likely market impact

Weak results with widening losses and revenue contraction may pressure the stock. Share capital reduction from a reversed SSPL deal awaits NCLT and exchange approvals.